Stay updated on Trivalent P2-VP8 Vaccine Clinical Trial
Sign up to get notified when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.

Latest updates to the Trivalent P2-VP8 Vaccine Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Gauteng as a location under the Locations section. Removed the prior Gauteng Locations entry and the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe Publications section now states entries are automatically filled from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2. The deletions explain that PubMed-based publications are auto-generated by ClinicalTrials.gov using the NCT number, replacing the prior wording that referenced v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange Detected- Removed the government funding status notice banner. The page now shows only the study details and related information without that banner.SummaryDifference0.3%

- Check63 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and structure appear unchanged.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a new version tag v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference2%

- Check98 days agoChange Detected- Added version update to v3.1.0. - Removed several MedlinePlus topics and MeSH terms related to drug safety and counterfeit drugs, and the older revision v3.0.2. Overall, the page’s core content remains largely the same, with a narrowed scope of topics.”} } } } cannot parse the extra characters? The final JSON should be valid: The wrapper required is {SummaryDifference0.4%

Stay in the know with updates to Trivalent P2-VP8 Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.